AAM
TMO icon

Arabesque Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Arabesque Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,160
Closed -$3.94M – 115
2022
Q4 		$3.94M Buy
7,160
+3,189
+80% +$1.69M 1.33% 18
2022
Q3 		$2.01M Sell
3,971
-165
-4% -$92.3K 0.98% 52
2022
Q2 		$2.25M Buy
4,136
+318
+8% +$175K 1.18% 15
2022
Q1 		$2.25M Buy
+3,818
New +$2.19M 0.78% 57
2021
Q4 		– Sell
-7,652
Closed -$4.37M – 203
2021
Q3 		$4.37M Buy
+7,652
New +$4.2M 1.46% 4
2021
Q2 		– Sell
-17,131
Closed -$7.82M – 159
2021
Q1 		$7.82M Buy
17,131
+11,347
+196% +$5.42M 3.46% 7
2020
Q4 		$2.69M Buy
+5,784
New +$2.71M 0.81% 28

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return